Compound Index
Peptide Research for Metabolic Syndrome: Insulin Resistance, Hypertension, and Dyslipidemia Protocols
A comprehensive research guide to metabolic syndrome biology and multi-compound peptide protocols: GLP-1 agonist data from STEP 1 and SELECT, MOTS-c AMPK/ACC mechanism, AOD-9604 β3-AR lipolysis, and NAD+/SIRT1 lipogenesis suppression — with 5-component endpoint battery, 8-group study design, and reconstitution/storage guidance.
GLP-1 Agonists and Appetite Regulation: Hypothalamic Circuits, Ghrelin, and Hunger Endpoint Study Design
A mechanistic deep dive into how GLP-1 agonists suppress appetite through hypothalamic ARC/VMH circuits, ghrelin/GLP-1 axis interplay, gastric emptying, and reward pathway modulation — with validated hunger endpoints and study design for preclinical metabolic research.
Semaglutide Weight Loss Plateau: Research Mechanisms and Protocol Adjustments
A research-focused deep dive into the biological mechanisms underlying weight loss plateaus during GLP-1 agonist treatment. Covers adaptive thermogenesis, counter-regulatory responses, receptor downregulation, and evidence-based protocol design strategies including dose escalation, compound cycling, and combination approaches.